PharmaVOICE - 
Nov./Dec. 2002
Purchase Issue

In Every Issue
Talent Pool
Pharma POOL Mark BOOTH Takeda Pharmaceuticals North America Names President [...]
By
E-Media
E-MEDIA NEW ELECTRONIC AND WEBBASED APPLICATIONS, SITES, AND TECHNOLOGIES FDAnews [...]
By
What’s New
NEW HEALTHCARERELATED PRODUCTS, SERVICES, AND COMPANIES Doctors+Designers has changed its [...]
By
PharmaTrax
SALES, MARKETING, AND R&D TRENDS AFFECTING THE HEALTHCARE INDUSTRY NestEggz [...]
By
For Art’s Sake
Catchy, creative, and memorable are three words to describe this [...]
By
Pharma Outlet
For the first time since the Food and Drug Administration [...]
By

Susan Hempstead

What’s on Your Mind: Opinions
The economy In my opinion, the biggest impact on the [...]
By
Raise your voice: Letters
Turn up the volume Each month, our team looks forward [...]
By
Letter from the Editor
PharmaVOICE A product lives on a shelf. A brand lives [...]
By

On The Cover

Brand Champions
The role of the is being played by branding companies, advertising agencies,by the companies that are in charge of producing materials and giving strategic advice to pharmaceutical companies.There are few companies that have a brand champion. Vince Parry TOO OFTEN BRANDING IS MISTAKEN FOR AN ADVERTISING CAMPAIGN, WHEN IN REALITY BRANDING SHOULDBEVIEWED AS CREATINGALASTINGBOND WITH [...]
By

Taren Grom, Editor

Features

Dr. Alan E. Guttmacher — In the genes
AS THE RECENTLY APPOINTED SECOND DEPUTY DIRECTOR OF THE NATIONAL HUMAN GENOME RESEARCH INSTITUTE,THE INSTITUTION RESPONSIBLE FOR LEADING THE HUMAN GENOME PROJECT, DR.ALAN GUTTMACHER’S EXTENSIVE CLINICAL GENETICS BACKGROUND WILL BE INVALUABLE AT A TIME WHEN RESEARCHERS ARE BEGINNING TO TRANSLATE THE INFORMATION CONTAINED IN THE NEARLY COMPLETED HUMAN GENOME SEQUENCE INTO MEDICAL ADVANCES. In the [...]
By

Kim Ribbink

No Pain, Big Gain
Daily injections are a painful way of life for an estimated 3.7 mil lion Americans who are insulin dependent diabetics. The condi tion, characterized by high blood sugar levels that result from defects in the body’s ability to produce and/or use insulin, is the fifth leading cause of death by disease in the U.S., and [...]
By

Elizabeth Pena

The Package Deal
PharmaVOICE Container or labeling of which, without authorization, bears the trademark, trade name, or other identifying mark, imprint, or device, or any likeness thereof, of a drug manufacturer, pro cessor, packer, or distributor other than the per son or persons who in fact manufactured, pro cessed, packed, or distributed such drug and which thereby falsely [...]
By

Elizabeth Pena

The Patient Pipeline
CLINICAL TRIAL RECRUITMENT AND ENROLLMENT EFFORTS ARE OFTEN NOT GIVEN HIGH PRIORITY, causing costly delays in the develop ment of new drugs. Unfortunately, there are no quick fixes, but companies are beginning to institute wellthought out and designed processes to bring the right patients to the right trials. Industry analysts intimate that one of the [...]
By

Denise Myshko

FEEDBACK